Adenosine A1, but not A2, receptor blockade increases anxiety and arousal in zebrafish

Basic and Clinical Pharmacology and Toxicology

Volumn 109, Issue 3, 2011, Pages 203-207

  Maximino, Caio ^a,b   Lima, Monica G ^a   Olivera, Karen R M ^a   Picanço Diniz, Domingos L W ^c   Herculano, Anderson M ^a,b  

^a FEDERAL UNIVERSITY OF PARÁ   (Brazil)

^b Zebrafish Neuroscience Research Consortium   (Brazil)

^c UNIVERSIDADE FEDERAL DO OESTE DO PARÁ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 DIMETHYL 1 PROPARGYLXANTHINE; 8 (2 AMINO 4 CHLOROPHENYL) 1,3 DIPROPYLXANTHINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2 RECEPTOR; ADENOSINE A2 RECEPTOR ANTAGONIST; CAFFEINE; PIGMENT; UNCLASSIFIED DRUG; XANTHINE DERIVATIVE; ADENOSINE A1 RECEPTOR ANTAGONIST;

ANIMAL EXPERIMENT; ANXIETY; AROUSAL; ARTICLE; AVOIDANCE BEHAVIOR; BEHAVIOR; CONTROLLED STUDY; DARKNESS; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; GENETIC CONSERVATION; LIGHT; LOCOMOTION; MELANOPHORE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; RECEPTOR BLOCKING; SEQUENCE ALIGNMENT; ZEBRA FISH; ANIMAL; ANIMAL BEHAVIOR; CATTLE; CHEMICALLY INDUCED DISORDER; METABOLISM; MOLECULAR GENETICS; MOTOR ACTIVITY; MOUSE; PHYSIOLOGY;

BOVINAE; DANIO RERIO; RODENTIA;

ADENOSINE A1 RECEPTOR ANTAGONISTS; ADENOSINE A2 RECEPTOR ANTAGONISTS; ANIMALS; ANXIETY; AROUSAL; BEHAVIOR, ANIMAL; CAFFEINE; CATTLE; DARKNESS; DOSE-RESPONSE RELATIONSHIP, DRUG; MELANOPHORES; MICE; MOLECULAR SEQUENCE DATA; MOTOR ACTIVITY; PIGMENTS, BIOLOGICAL; RECEPTOR, ADENOSINE A1; RECEPTORS, ADENOSINE A2; SEQUENCE ALIGNMENT; ZEBRAFISH;

EID: 80051589608     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2011.00710.x     Document Type: Article

References (58)

1. Fredholm BB. Adenosine, adenosine receptors and the actions of caffeine. Pharmacol Toxicol 1995;76:93-101.
2. Fredholm BB, Battig K, Holmen J, Nehlig A, Zvartau EE. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev 1999;51:83-133.
3. Baldwin HA, File SE. Caffeine-induced anxiogenesis: the role of adenosine, benzodiazepine and noradrenergic receptors. Pharmacol Biochem Behav 1989;32:181-6.
4. Bhattacharya SK, Satyan KS, Chakrabarti A. Anxiogenic action of caffeine: an experimental study in rats. J Psychopharmacol 1997;11:219-24.
5. Baldwin HA, Johnston AK, File SE. Antagonistic effects of caffeine and yohimbine in animal tests of anxiety. Eur J Neurosci 1989;159:211-5.
6. Costall B, Jones BJ, Kelly ME, Naylor RJ, Tomkins DM. Exploration of mice in a black and white test box: validation as a model of anxiety. Pharmacol Biochem Behav 1989;32:777-85.
7. Imaizumi M, Miyazaki S, Onodera K. Effects of xanthine derivatives in a light/dark test in mice and the contribution of adenosine receptors. Methods Find Exp Clin Pharmacol 1994;16:639-44.
8. Pellow S, Chopin P, File SE, Briley M. Validation of open:Closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 1985;14:149-67.
9. 2A receptors in psychiatric disorders. Curr Pharm Des 2008;14:1512-24.
10. Jain N, Kemp N, Adeyemo O, Buchanan P, Stone TW. Anxiolytic activity of adenosine receptor activation in mice. Br J Pharmacol 1995;116:2127-33.
11. 1 receptors modulate anxiety in CD1 mice. Psychopharmacology 1998;136:311-9.
12. 1 receptors modulate the anxiolytic-like effect of ethanol in the elevated plus-maze in mice. Eur J Pharmacol 2004;499:147-54.
13. 1 receptors reduces anxiety-like behavior during acute ethanol withdrawal (hangover) in mice. Neuropsychopharmacology 2006;31:2210-20.
14. Lang UE, Lang F, Richter K, Vallon V, Lipp H-P, Schnermann J et al. Emotional instability but intact spatial cognition in adenosine receptor 1 knock out mice. Behav Brain Res 2003;145:179-88.
15. Johansson B, Halldner L, Dunwiddie TV, Masino SA, Poelchen W, Giménez-Llort L et al. Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor. Proc Natl Acad Sci USA 2001;98:9407-12.
16. Choi OH, Shamin MT, Padgett WT, Daly JW. Caffeine and teophylline analogues: correlation of behavioral effects with activity as adenosine receptor antagonists and as phosphodiesterase inhibitors. Life Sci 1988;43:397.
17. Holtzman SG, Finn I. Tolerance to behavioral effects of caffeine in rats. Pharmacol Biochem Behav 1988;29:411.
18. Damianopoulos EN, Carey RJ. Caffeine effects on locomotor and reward behavior. In: Gupta BS, Gupta U (eds). Caffeine and Behavior: Current Views and Research Trends. CRC Press, Boca Raton, 1999;49-74.
19. 2 receptors in rat striatal membranes. Proc Natl Acad Sci USA 1991;88:7238-41.
20. 2 receptors for dopamine in human striatum. NeuroReport 2001;12:1831-4.
21. 2-adenosine antagonist in vitro and in vivo. FEBS Lett 1993;323:141-44.
22. 1 receptor inhibition. Neuroscience 2002;112:319-29.
23. 2A adenosine receptor antagonists. Psychopharmacology 2000;148:153-63.
24. 2A receptor. Nature 1997;388:674-8.
25. 2A receptor knockout mouse: A model for anxiety? Int J Neuropsychopharmacol 1998;1:187-90.
26. 2a receptor gene polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology 2003;28:1694-702.
27. 2a adenosine receptor genes in panic disorder suggest a contribution of the A2a gene to the development of disease. Mol Psychiatry 1998;3:81-5.
28. 1 adenosine receptors, adenosine deaminase and adenosine deaminase-binding protein (CD26) in goldfish brain. Neurochem Intl 2003;42:455-64.
29. a adenosine receptors in the brain of the low vertebrate teleost Carassius auratus (Goldfish). Neurochem Intl 1995;26:411-23.
30. Boehmler W, Petko J, Woll M, Frey C, Thisse B, Thisse C et al. Identification of zebrafish A2 adenosine receptors and expression in developing embryos. Gene Expr Patt 2009;9:144-51.
31. Egan RJ, Bergner CL, Hart PC, Cachat JM, Canavello PR, Elegante MF et al. Understanding behavioral and physiological phenotypes of stress and anxiety in zebrafish. Behav Brain Res 2009;205:38-44.
32. Gerlai R. Zebrafish antipredatory responses: a future for translational research? Behav Brain Res 2009;207:223-31.
33. Maximino C, Brito TM, Dias CAGM, Gouveia A Jr, Morato S. Scototaxis as anxiety in fish. Nature Prot 2010;5:209-16.
34. Maximino C, Brito TM, Morato S, Gouveia A Jr. Measuring anxiety in zebrafish: a critical review. Behav Brain Res 2010;214:157-71.
35. Stewart A, Maximino C, Brito TM, Herculano AM, Gouveia A Jr, Morato S et al. Neurophenotyping of adult zebrafish using the light/dark box paradigm. In: Kalueff AV, Cachat J (eds). Zebrafish neurobehavioral protocols. Humana Press, New York, 2010; 157-67.
36. Wong K, Elegante MF, Bartels BK, Elkhayat SI, Tien DH, Roy S et al. Analyzing habituation responses to novelty in zebrafish (Danio rerio). Behav Brain Res 2010;208:450-7.
37. Maximino C, Silva AWB, Gouveia A Jr, Herculano AM. Pharmacological analysis of zebrafish (Danio rerio) scototaxis. Prog Neuropsychopharmacol Biol Psychiatry 2011;35:624-31.
38. Hewer HR. Studies in colour changes of fish Part II - An analysis of the colour patterns of the dab. Part III - The action of nicotin and adrenalin in the dab. Part IV - The action of caffeine in the dab, and a theory of the control of colour changes in fish. Phil Trans Royal Soc London B 1927;215:177-200.
39. Fujii R, Miyashita Y Beta adrenoceptors, cyclic AMP and melanosome dispersion in guppy melanophores. In: Riley V (ed.). Pigment Cell. Karger, Basel, 1976; 336-44.
40. Miyashita Y, Kuwazawa T, Fujii R. Receptor mechanisms in fish chromatophores - VI. Adenosine receptors mediated pigment dispersion in guppy and catfish melanophores. Comp Biochem Physiol C 1984;77:205-10.
41. Oshima N, Yamaji N, Fujii R. Adenosine receptors mediate pigment dispersion in leucophores of the medaka, Oryzias latipes. Comp Biochem Physiol C 1986;85:245-8.
42. Namoto S. A subtype of adenosine receptors mediating pigment dispersion in leucophores of the medaka: evidance for an A2-receptor. Comp Biochem Physiol C 1987;88:75-81.
43. Fujii R. The regulation of motile activity in fish chromatophores. Pigment Cell Res 2000;13:300-19.
44. Bernier NJ, Fuentes J, Randall DJ. Adenosine receptor blockade and hypoxia tolerance in ranbow trout and Pacific hagfish: II Effects on plasma catecholamines and erythrocytes. J Exp Biol 1996;199:497-507.
45. Bernier NJ, Perry SF. Control of catecholamine and serotonin release from the chromaffin tissue of the Atlantic hagfish. J Exp Biol 1996;199:2485-97.
46. Jacobson KA, Van Rhee AM. Development of selective purinoceptor agonists and antagonists. In: Jacobson KA, Jarvis MF (eds.). Purinergic approaches in experimental therapeutics. Wiley-Liss, New York, 1997;101-28.
47. Burnstock G, Hoyle CH. PACPX - a substituted xanthine - antagonizes both the A1 and A2 subclasses of the P1-purinoceptor: antagonism of the A2 subclass is competitive but antagonism of the A1 subclass is not. Br J Pharmacol 1985;85:291-6.
48. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG. The ClustalX windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 1997;25:4876-82.
49. 1 adenosine receptor: studies on the ligand binding site by site-directed mutagenesis. J Biol Chem 1992;267:10764-70.
50. ASAB/ABS. Guidelines for the treatment of animals in behavioural research and teaching. Anim Behav 2006;71:245-53.
51. Andersen ML, D'Almeida V, Ko GM, Kawakami R, Martins PJF, Magalhães LE et al. Princípios Éticos e Práticos do Uso de Animais de Experimentação. Universidade Federal Paulista/SBCAL, São Paulo, 2008.
52. 1-selective antagonist, DPCPX. Psychopharmacology 1991;103:541-4.
53. 2A receptor heteromers. J Neurosci 2006;26:2080-7.
54. 2A receptor-mediated facilitation of plasticity. Neurochem Int 2008;52:65-72.
55. Giménez-Llort L, Fernández-Teruel A, Escorihuela RM, Fredholm BB, Tobeña A, Pekny M et al. Mice lacking the adenosine A1 receptor are anxious and aggressive, but are normal learners with reduced muscle strength and survival rate. Eur J Neurosci 2002;16:547-50.
56. Svenningsson P, Nomikos GG, Fredholm BB. Biphasic changes in locomotor behavior and in expression of mRNA for NGFI-A and NGFI-B in rat striatum following acute caffeine administration. J Neurosci 1995;15:7612-24.
57. Daly JW, Fredholm BB. Caffeine - An atypical drug of dependence. Drug Alcohol Depend 1998;51:199-206.
58. Best JD, Berghmans S, Hunt JJFG, Clarke SC, Fleming A, Goldsmith P et al. Non-associative learning in larval zebrafish. Neuropsychopharmacology 2008;33:1206-15.